Evommune is a biotechnology company that develops new treatments for inflammatory diseases. Its main products are immune-focused drug candidates for patients and healthcare providers in dermatology and immunology care.
Evommune products and services overview:
Revenue: ~$0 million
Employees: 80
Headquarters: Palo Alto, United States (USA)
Evommune is one of the...
Evommune is a company listed under the stock ticker EVMN (US).
Acquisition, funding and merger involving Evommune.
View the org chart displaying its 23 main executives
Create your alert
to follow the executive moves at Evommune.
Evommune has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).
Discover the organization charts of your favorite companies.
Spot the influential executives using our search tools.
Receive notifications when executive positions change.